Comment

  • 24 April 2018

    Tremfya approval: increasing options for psoriasis treatment

    Johnson & Johnson’s (J&J) Tremfya (guselkumab) has recently been granted approval for the treatment of adults suffering from moderate-to-severe plaque psoriasis in Australia, Brazil, and Japan. J&J has licensed Tremfya...